Skip to main content Accessibility help
×
Hostname: page-component-7479d7b7d-767nl Total loading time: 0 Render date: 2024-07-12T20:55:46.089Z Has data issue: false hasContentIssue false

121 - Reserpine

Published online by Cambridge University Press:  06 October 2020

Stephen D. Silberstein
Affiliation:
Thomas Jefferson University, Philadelphia
Michael J. Marmura
Affiliation:
Thomas Jefferson University, Philadelphia
Hsiangkuo Yuan
Affiliation:
Thomas Jefferson University, Philadelphia
Stephen M. Stahl
Affiliation:
University of California, San Diego
Get access

Summary

THERAPEUTICS

Brands

• Harmonyl

Generic?

• Yes

Class

• Monoamine-depleting agent

Commonly Prescribed for

(FDA approved in bold)

Hypertension

Psychotic states

• Gilles de la Tourette syndrome (GTS) or tics

• Chorea and dyskinesias in Huntington’s disease

• Hemiballism

• Dystonia (especially tardive)

• Myoclonus

How the Drug Works

• Depleting agent that depletes stores of catecholamines (dopamine, norepinephrine) and serotonin in the brain and adrenal medulla. Depression of sympathetic nerve function lowers heart rate and blood pressure

How Long Until It Works

• Hypertension: less than a week

• Psychosis, movement disorders: effects can be seen within a few days

If It Works

• In neurological conditions, continue to assess effect of the medication and determine if still needed

If It Doesn't Work

• Chorea: consider benzodiazepines and AEDs (valproate). Neuroleptics are usually effective. Tetrabenazine (another antiadrenergic) is often better tolerated

• Generalized dystonia: anticholinergics, baclofen, or benzodiazepines may be effective. Surgical treatments (including pallidotomy, thalamotomy, deep brain stimulation, myotomy, rhizotomy, or peripheral denervation) are reserved for refractory cases

• GTS/tics: neuroleptics and α2-adrenergic agonists are often effective

Best Augmenting Combos for Partial Response or Treatment-Resistance

• AEs, such as CNS depression, often increase when used with other agents, but if tolerated consider combinations with AEDs or benzodiazepines

Tests

• Monitor blood pressure and pulse

ADVERSE EFFECTS (AEs)

How the Drug Causes AEs

• Related to depletion of catecholamines and serotonin

Notable AEs

• Bradycardia, edema, angina-like symptoms

• Drowsiness, dizziness, depression, nightmares

• Nausea, dry mouth, anorexia, impotence, dyspnea, nasal congestion

• Rash, purpura

Life-Threatening or Dangerous AEs

• Hypersensitivity reactions

• Deafness, optic atrophy

• Parkinsonism and extrapyramidal tract dysfunction (less common than neuroleptics)

Weight Gain

• Common

Weight Gain

• Common

Sedation

• Problematic

What to Do About AEs

• Stop drug for serious AEs, and use the lowest needed dose

Type
Chapter
Information
Essential Neuropharmacology
The Prescriber's Guide
, pp. 446 - 448
Publisher: Cambridge University Press
Print publication year: 2015

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Reserpine
  • Stephen D. Silberstein, Thomas Jefferson University, Philadelphia, Michael J. Marmura, Thomas Jefferson University, Philadelphia, Hsiangkuo Yuan, Thomas Jefferson University, Philadelphia
  • Edited in consultation with Stephen M. Stahl, University of California, San Diego
  • Book: Essential Neuropharmacology
  • Online publication: 06 October 2020
  • Chapter DOI: https://doi.org/10.1017/9781316161753.122
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Reserpine
  • Stephen D. Silberstein, Thomas Jefferson University, Philadelphia, Michael J. Marmura, Thomas Jefferson University, Philadelphia, Hsiangkuo Yuan, Thomas Jefferson University, Philadelphia
  • Edited in consultation with Stephen M. Stahl, University of California, San Diego
  • Book: Essential Neuropharmacology
  • Online publication: 06 October 2020
  • Chapter DOI: https://doi.org/10.1017/9781316161753.122
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Reserpine
  • Stephen D. Silberstein, Thomas Jefferson University, Philadelphia, Michael J. Marmura, Thomas Jefferson University, Philadelphia, Hsiangkuo Yuan, Thomas Jefferson University, Philadelphia
  • Edited in consultation with Stephen M. Stahl, University of California, San Diego
  • Book: Essential Neuropharmacology
  • Online publication: 06 October 2020
  • Chapter DOI: https://doi.org/10.1017/9781316161753.122
Available formats
×